These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7547519)

  • 1. Simultaneous carboplatin and radiotherapy for all stages of head and neck squamous cell carcinoma.
    Hosokawa Y; Kamada T; Shirato H; Ohmori K; Yasuda M; Yahata H; Nishioka T; Kitahara T; Arimoto T; Inuyama Y
    Clin Oncol (R Coll Radiol); 1995; 7(3):168-72. PubMed ID: 7547519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II trial of concomitant chemoradiotherapy using weekly carboplatin or daily low-dose cisplatin for squamous cell carcinoma of the head and neck.
    Homma A; Shirato H; Furuta Y; Nishioka T; Oridate N; Tsuchiya K; Nagahashi T; Aoyama H; Inuyama Y; Fukuda S
    Cancer J; 2004; 10(5):326-32. PubMed ID: 15530262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unresectable primary and recurrent head and neck tumors: effect of hyperthermia and carboplatin--preliminary experience.
    Chang P; Sapozink MD; Grunberg SM; Jozsef G; Rice DM; Formenti SC; Streeter OE
    Radiology; 2000 Mar; 214(3):688-92. PubMed ID: 10715031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous radiotherapy and chemotherapy with carboplatin in inoperable squamous cell carcinoma of the head and neck: a phase II study.
    Zamboglou N; Achterrath W; Schnabel T; Lenaz L; Kolotas C; Schmitt G
    Cancer Invest; 1992; 10(5):349-55. PubMed ID: 1393686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
    Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
    Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II study of concurrent weekly carboplatin and radiation therapy in advanced head and neck cancer.
    Ackland SP; Hamilton CS; Joseph DJ; Denham JW
    Clin Oncol (R Coll Radiol); 1993; 5(3):133-8. PubMed ID: 8347534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined radiochemotherapy with carboplatin in the treatment of advanced head and neck carcinomas.
    Schnabel T; Zamboglou N; Kolotas C; Hartmann A; Schmitt G
    Oncology; 1993 Nov; 50 Suppl 2():16-22. PubMed ID: 8233296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer.
    Wanebo HJ; Chougule P; Akerley WL; Koness RJ; McRae R; Nigri P; Leone L; Ready N; Safran H; Webber B; Cole B
    Am J Surg; 1997 Nov; 174(5):518-22. PubMed ID: 9374228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
    Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
    Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A long-term follow-up study after split-course irradiation with concurrent chemotherapy (carboplatin) for locally advanced head and neck cancer and a review of the literature.
    Pradier O; Christiansen H; Ambrosch P; Kron M; Schmidberger H; Hess CF
    ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):325-31. PubMed ID: 15668532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of simultaneous carboplatin and radiotherapy in unresectable squamous cell carcinoma of the head and neck.
    Volling P; Staar S; Achterrath W; Müller RP
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):66-71. PubMed ID: 1411629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results.
    Chougule P; Wanebo H; Akerley W; McRae R; Nigri P; Leone L; Safran H; Ready N; Koness RJ; Radie-Keane K; Cole B
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-57-S19-61. PubMed ID: 9427268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of carboplatin and paclitaxel with daily radiotherapy in patients with locally advanced squamous cell carcinomas of the head and neck.
    Suntharalingam M; Haas ML; Conley BA; Egorin MJ; Levy S; Sivasailam S; Herman JM; Jacobs MC; Gray WC; Ord RA; Aisner JA; Van Echo DA
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):49-56. PubMed ID: 10758304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
    Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant radiotherapy and daily low-dose carboplatin in locally advanced, unresectable head and neck cancer. Definitive results of a phase I-II study.
    Orecchia R; Ragona R; Airoldi M; Gabriele P; Gribaudo S; Grazia Ruo Redda M; Bussi M; Cavalot A; Rampino M; Sannazzari GL
    Acta Oncol; 1994; 33(5):541-5. PubMed ID: 7917369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.